Search

for
Search:

GlossaryTroglitazone

medication for type 2 diabetes, withdrawn due to liver toxicity

Troglitazone, also known as Rezulin, is a medication that was used to treat type 2 diabetes by improving insulin sensitivity. However, it was withdrawn from the market due to severe liver toxicity and associated health risks.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 180 results

research Treatment of Lipodystrophy with Troglitazone

1 citations, June 2001 in “Annals of Internal Medicine”

Troglitazone increases subcutaneous fat in lipodystrophy patients.

research Obesity and Polycystic Ovary Syndrome

90 citations, January 2021 in “Clinical Endocrinology”

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

research Insulin-Lowering Medications in Polycystic Ovary Syndrome

39 citations, September 2000 in “Obstetrics and Gynecology Clinics of North America”

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

research Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome

32 citations, July 2001 in “Endocrine Practice”

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

research Insulin Resistance and Polycystic Ovary Syndrome

November 2004 in “John Wiley & Sons, Ltd eBooks”

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

View more "troglitazone" in research →

Community Join

0 / 0 results

— no results